Coherence Neuro has raised $45M for an implant that records tumour signals and stimulates them, though human data remains limited…
NeoGenomics has expanded its partnership with Indica Labs, adopting the HALO AP platform as the cloud-based foundation for its digital…
SimBioSys has secured 510(k) clearance from the FDA for TumorSight Risk, a prognostic tool that estimates breast cancer recurrence risk…
An AI that reads routine tumor slides alongside clinical notes separated two groups of high-risk patients whose five-year outcomes diverged…
The oncology trial matching company joins OpenAI's Select tier to pair frontier models with cancer care workflows.